Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07394361
Eligibility Criteria:
Inclusion Criteria:
* being a woman between the 18 Years to 65 Years ,
* meeting the American College of Rheumatology SLE diagnostic criteria,
* having low disease activity (SLEDAI ≤4),
* agreeing to participate in the study
Exclusion Criteria:
* presence of malignancy, pregnancy, change of treatment within the last 3 months,
* use of steroids equivalent to \>16 mg prednisolone for the last 3 months, - -
* have other rheumatic diseases,
* have a regular exercise habit (physical activity more than two times a week),
* have a disease that restricts physical activity (such as neurological disorder, orthopedic disorder, cognitive disorder, immobility),
* have serious heart, lung or kidney involvement,
* uncontrolled hypertension,
* severe anemia (hb \<8 g/dL),
* having undergone orthopedic surgery in the last 6 months
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT07394361
Study Brief:
Protocol Section:
NCT07394361